Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting
ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ:FEMY), a biomedical company aiming to meet women’s needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company’s management team will be attending the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM) being held May 19-21, 2023 in Baltimore, Maryland. ACSM is a scienfific meeting for the leading experts in obstetrics and gynecology.
Related news for (FEMY)
- Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/08/25 01:00 PM
- 24/7 Market News Snapshot 08 September, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)
- 24/7 Market News Snapshot 08 September, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)
- Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control